Zhang X, Zhang X, Jia Q, Li H, Ma R, Yang G, et al. LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis. BMC Cancer. 2022;22(1):344.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Rosario PW, dos Santos JB, Calsolari MR. Follow-up of patients with low-risk papillary thyroid carcinoma and undetectable basal serum thyroglobulin after ablation measured with a sensitive assay: a prospective study. Horm Metab Res. 2013;45(12):911–4.

Article  CAS  PubMed  Google Scholar 

Wu DM, Wang S, Wen X, Han XR, Wang YJ, Shen M, et al. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma. Cell Death Dis. 2018;9(10):947.

Article  PubMed  PubMed Central  Google Scholar 

Xiong M, Wu M, Dan P, Huang W, Chen Z, Ke H, et al. LncRNA DANCR represses Doxorubicin-induced apoptosis through stabilizing MALAT1 expression in colorectal cancer cells. Cell Death Dis. 2021;12(1):24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xue C, Cheng Y, Wu J, Ke K, Miao C, Chen E, et al. Circular RNA CircPRMT5 accelerates Proliferation and Invasion of Papillary thyroid Cancer through regulation of miR-30c/E2F3 Axis. Cancer Manag Res. 2020;12:3285–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di Gesualdo F, Capaccioli S, Lulli M. A pathophysiological view of the long non-coding RNA world. Oncotarget. 2014;5(22):10976–96.

Article  PubMed  PubMed Central  Google Scholar 

Luo Y, Wang Q, Teng L, Zhang J, Song J, Bo W, et al. LncRNA DANCR promotes proliferation and metastasis in pancreatic cancer by regulating miRNA-33b. FEBS Open Bio. 2020;10(1):18–27.

Article  CAS  PubMed  Google Scholar 

Tao L, Tian P, Yang L, Guo X. lncRNA CASC2 enhances (131)I sensitivity in papillary thyroid Cancer by sponging miR-155. Biomed Res Int. 2020;2020:7183629.

Article  PubMed  PubMed Central  Google Scholar 

Ren N, Jiang T, Wang C, Xie S, Xing Y, Piao D, et al. LncRNA ADAMTS9-AS2 inhibits gastric cancer (GC) development and sensitizes chemoresistant GC cells to cisplatin by regulating miR-223-3p/NLRP3 axis. Aging. 2020;12(11):11025–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liao B, Liu S, Liu J, Reddy PAK, Ying Y, Xie Y, et al. Long noncoding RNA CTC inhibits Proliferation and Invasion by Targeting miR-146 to regulate KIT in papillary thyroid carcinoma. Sci Rep. 2020;10(1):4616.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liang Y, Chen X, Wu Y, Li J, Zhang S, Wang K, et al. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein. Cell Death Differ. 2018;25(11):1980–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao J, Fu J, Liu Y, Qu W, Wang G, Yan Z. LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p. Ann Hepatol. 2021;23:100297.

Article  CAS  PubMed  Google Scholar 

Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5–18.

Article  CAS  PubMed  Google Scholar 

Zhao W, Geng D, Li S, Chen Z, Sun M. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018;7(3):842–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu F, Zhang J, Qin L, Yang Z, Xiong J, Zhang Y, et al. Circular RNA EIF6 (Hsa_circ_0060060) sponges mir-144-3p to promote the cisplatin-resistance of human thyroid carcinoma cells by autophagy regulation. Aging. 2018;10(12):3806–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wen J, Wang H, Dong T, Gan P, Fang H, Wu S, et al. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway. Cell Prolif. 2019;52(2):e12569.

Article  PubMed  PubMed Central  Google Scholar 

Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (Lond). 2021;41(2):109–20.

Article  PubMed  Google Scholar 

Tang W, Yu X, Zeng R, Chen L. LncRNA-ATB promotes Cisplatin Resistance in Lung Adenocarcinoma cells by targeting the miR-200a/β-Catenin pathway. Cancer Manag Res. 2020;12:2001–14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yue X, Wu WY, Dong M, Guo M. LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p. Biomed J. 2021;44(6 Suppl 2):S296–304.

Article  CAS  PubMed  Google Scholar 

Chen Z, Chen Q, Cheng Z, Gu J, Feng W, Lei T, et al. Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1. Cell Death Dis. 2020;11(10):858.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sun G, Guo F, Wu X, Han L, Xue J. LncRNA CASC9 regulates cell proliferation, apoptosis and cell cycle via sponging mir-145-5p in colon cancer cells. Transl Cancer Res. 2019;8(8):2769–80.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Li Y, Gao H. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p. Cancer Med. 2020;9(5):1830–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu Y, Li G, Ma Y, Luo G, Wang Q, Zhang S. Effect of Exosomal lncRNA MALAT1/miR-370-3p/STAT3 positive feedback Loop on PI3K/Akt pathway mediating Cisplatin Resistance in Cervical Cancer cells. J Oncol. 2023;2023:6341011.

Article  PubMed  PubMed Central  Google Scholar 

Wu Q, Ma J, Wei J, Meng W, Wang Y, Shi M. FOXD1-AS1 regulates FOXD1 translation and promotes gastric cancer progression and chemoresistance by activating the PI3K/AKT/mTOR pathway. Mol Oncol. 2021;15(1):299–316.

Article  CAS  PubMed  Google Scholar 

Fang J, Li K, Huang C, Xue H, Ni Q. LncRNA TTN-AS1 confers tamoxifen resistance in breast cancer via sponging miR-107 to modulate PI3K/AKT signaling pathway. Am J Transl Res. 2022;14(4):2267–79.

CAS  PubMed  PubMed Central  Google Scholar 

Prinz F, Kapeller A, Pichler M, Klec C. The implications of the long non-coding RNA NEAT1 in non-cancerous diseases. Int J Mol Sci. 2019;20(3).

Zheng J, Wang J, Jia Y, Liu T, Duan Y, Liang X, et al. microRNA-211 promotes proliferation, migration, and invasion ability of oral squamous cell carcinoma cells via targeting the bridging integrator 1 protein. J Cell Biochem. 2019;120(3):4644–53.

Article  CAS  PubMed  Google Scholar 

Zhang J, Yao Y, Li H, Ye S. Mir-28-3p inhibits prostate cancer cell proliferation, migration and invasion, and promotes apoptosis by targeting ARF6. Exp Ther Med. 2021;22(5):1205.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mao W, Wan